CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to DMAC

Recombinant human tissue kallikrein

Phase 3
DiaMedica Therapeutics Inc. (DMAC)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
DMACPhase 3

Recombinant human tissue kallikrein Phase 3 Est. Readout

Recombinant human tissue kallikrein
Dec 2026~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Acute Stroke

View Full Landscape
Drug Information

Target Indication

Acute Stroke

Clinical Trial

NCT05065216

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.